Form 4: UiPath CEO Daniel Dines Sells $731K in Stock

UiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $731,515 on December 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Daniel Dines, CEO and Chairman of UiPath, Inc. (PATH), sold 45,000 shares of the company's Class A Common Stock.
• The transaction occurred on December 16, 2025.
• The shares were sold at an average price of $16.2559 per share, with prices ranging from $16.1600 to $16.3700.
• The total value of the shares sold was approximately $731,515.50.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which allows insiders to sell shares at a predetermined time or price to avoid accusations of insider trading.
• Following this transaction, Daniel Dines beneficially owns 28,928,585 shares of Class A Common Stock directly.

Sentiment

Score: 6

Explanation: The sale of shares by the CEO is generally a neutral to slightly negative signal, but the execution under a Rule 10b5-1 plan mitigates concerns, indicating a pre-planned personal financial move rather than a reaction to new negative information.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate, non-public information, which can reduce negative market perception.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived by the market as a slight reduction in confidence, though this is mitigated by the planned nature of the transaction.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general market perception of insider selling.

Future Outlook

NA

Industry Context

This Form 4 filing reports a routine insider stock sale by UiPath's CEO. Such sales are common among executives for personal financial planning and diversification, especially when executed under a Rule 10b5-1 plan, which is a standard practice in the industry to manage insider trading compliance.

Stakeholder Impact

• Shareholders may view the insider sale with slight caution, though the Rule 10b5-1 plan reduces the likelihood of it being interpreted as a lack of confidence in the company's future prospects.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider stock sale by the CEO. While insider selling can sometimes be a negative signal, the execution under a Rule 10b5-1 plan suggests personal financial planning rather than a change in fundamental outlook. The transaction itself is not significant enough to warrant a change in investment recommendation based solely on this filing.

Keywords

UiPath, PATH, Daniel Dines, Insider Sale, Form 4, 10b5-1 Plan, CEO, Stock Transaction, Equity Sale